Morning Briefing
Summaries of health policy coverage from major news organizations
Federal Appeals Court Declines To Reconsider 'Pay-For-Delay' On Generic Drugs
A federal appeals court on Tuesday said it will not revisit its decision to uphold settlements that allow pharmaceutical companies to pay competitors to keep generic versions of their drugs off the market, The Wall Street Journal reports.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
